In the gastric cancer (GC) tumor microenvironment (TME), tumors and stromal cells upregulate CD39/CD73, hijacking purinergic signaling to promote adenosine accumulation and activate Adora2b. This evidence concerns the gene ADORA2B and gastric cancer.